Clinuvel Pharmaceuticals Stock
Clinuvel Pharmaceuticals Stock
There is an upward development for Clinuvel Pharmaceuticals compared to yesterday, with an increase of €0.062 (1.050%).
Our community identified positive and negative aspects for Clinuvel Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Clinuvel Pharmaceuticals stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Clinuvel Pharmaceuticals in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clinuvel Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clinuvel Pharmaceuticals | 1.050% | 4.785% | -3.568% | -11.894% | -15.074% | -47.667% | -64.758% |
| Pharma Mar S.A. | 3.290% | 9.838% | 10.338% | 3.856% | 12.757% | 148.099% | 21.701% |
| Mayne Pharma Group Ltd. | -2.300% | 4.938% | 16.438% | -35.115% | 4.938% | -39.286% | 996.774% |
| Polynovo Ltd | 3.770% | 11.336% | -5.172% | -13.386% | -19.118% | -40.217% | -60.145% |
